Dr Reddys Laboratories Upgraded to Hold on Technical and Valuation Improvements

robot
Abstract generation in progress

Dr Reddy’s Laboratories Ltd. has been upgraded from a Sell to a Hold rating as of February 26, 2026, due to improvements in technical indicators, valuation, and fundamental financial trends. While the company’s long-term financials remain strong, recent quarterly results showed some weakness. The upgrade reflects a stabilization in price momentum and attractive valuation despite slower profit growth, warranting a cautious outlook.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)